Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran

Tropical Biomedicine

Volumn 27, Issue 3, 2010, Pages 476-482

  Daryani, Ahmad ^a   Sharif, Mehdi ^a   Hosseini, Sayed Hamzeh ^a   Karimi, Sayed Ahmad ^a   Gholami, Shirzad ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ADULT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; IRAN; MALE; MENTAL HOSPITAL; SCHIZOPHRENIA; TOXOPLASMA; TOXOPLASMOSIS;

ADULT; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IRAN; MALE; SCHIZOPHRENIA; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 78650789872     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Alvarado-Esquivel, C., Sifuentes-Alvarez, A., Narro-Duarte, S.G., Estrada-Martinez, S., Diaz-Garcia, J.H., Liesenfeld, O., Martínez-García, S.A. & Canales-Molina, A. (2006). Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC infectious Diseases 6: 113.
2. Arendt, G., Von Giesen, H.J., Hefter, H., Neuen-Jacob, E., Roick, H. & Jablonowski, H. (1999). Long-term course and outcome in AIDS patients with cerebral toxoplasmosis. Acta Neurologica Scandinavica 100: 178-184.
3. Boronow, J., Dickerson, F., Stallings, C., Lee, B., Origoni, A. & Yolken, R. (2002). HSV-1, CMV and Toxoplasma serology predict cognitive deficits in schizophrenia. Schizophrenia Research 53: 85.
4. Bossi, P., Caumes, E., Paris, L., Darde, M.L. & Bricaire, F. (1998). Toxoplasma gondii-associated Guillain-Barre syndrome in an immunocompetent patients. Journal of Clinical Microbiology 36: 3724-3725.
5. Brown, A.S., Schaefer, C.A., Quesenberry, C.S., Liu, L., Babulas, V.P. & Susser, E.S. (2005). Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. American Journal of Psychiatry 162(4): 767-773.
6. Carme, B., Bissuel, F., Ajzenberg, D., Bouyne, R., Aznar, C., Demar, M., Bichat, S., Louvel, D., Bourbigot, A.M., Peneau, C., Neron, P. & Dardé, M.L. (2002). Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. Journal of Clinical Microbiology 40: 4037-4044.
7. Carruthers, V.B. & Blackman, M.J. (2005). A new release on life: emerging concepts in proteolysis and parasite invasion. Molecular Microbiolog 55: 1617-1630.
8. Cetinkaya, Z., Yazar, S., Gecici, O. & Namli. (2007). Anti-Toxoplasma gondii antibodies in patients with schizophrenia-preliminary findings in a Turkish sample. Schizophrenia Bulletin 33(3): 789-791.
9. Cook, I. & Derrick, E.H. (1961). The incidence of Toxoplasma antibodies in mental hospital patients. Australasian Annals of Medicine 10: 137-141.
10. Creuzet, C., Robert, F., Roisin, M. P., Van Tan, H., Benes, C., Dupouy-Camet, J. & Fagard, R. (1998). Neurons in primary cultures are less efficiently infected by Toxoplasma gondii than glia cells. Parasitology Research 84: 25-30.
11. Daubener, W. & Hadding, U. (1997). Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system. Medical Microbiology and Immunology 185: 195-206.
12. Dawson, D. (2005). Foodborne protozoan parasites. International Journal of Food Microbiology 105: 207-227.
13. Dubey, J.P. (2004). Toxoplasmosis-a waterborne zoonosis. Veterinary Parasitology 126: 57-72.
14. Fischer, H.G., Nitzgen, B., Reichmann, G., Gross, U. & Hadding, U. (1997). Host cells of Toxoplasma gondii encystations in infected primary culture from mouse brain. Parasitology Research 83: 637-641.
15. Flegr, J., Zitkova, S., Kodym, P. & Frynta, D. (1996). Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 113: 49-55.
16. Flegr, J., Preiss, M., Klose, J., Havlicek, J., Vitakova, M. & Kodym, P. (2003). Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii. Transactions of the Royal Society of Tropical Medicine and Hygiene 63: 253-268.
17. Fujigaki, S., Takemura, M., Hamakawa, H., Seishima, M. & Saito, K. (2003). The mechanism of interferon-gamma induced anti Toxoplasma gondii by 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues. Advances in Experimental Medicine and Biology 527: 97-103.
18. Garrido, J.A. & Redondo, V.P. (1968). Toxoplasmosis y enfermedades mentales. Archivos de Neurobiologiá 31: 161-172.
19. Ghorbani, M., Edrisian, Gh. H. & Assad, N. (1978). Serological survey of toxoplasmosis in the northern part of Iran, using indirect antibody technique. Transactions of the Royal Society of Tropical Medicine and Hygiene 4: 369-371.
20. Grigg, M.E., Bonnefoy, S., Hehl, A.B., Suzuki, Y. & Boothroyd, J.C. (2001). Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 294: 161-165.
21. Gu, H., Yolken, R.H., Phillips, M., Yange, F., Bilder, R.M. & Gilmore, J.H. (2001). Evidence of Toxoplasma gondii infection in recent-onset schizophrenia. Schizophrenia Research 49: 53.
22. Halonen, S.K., Lyman, W.D. & Chiu, F.C. (1996). Growth and development of Toxoplasma gondii in human neurons and astrocytes. Journal of Neuropathology and Experimental Neurology 55: 1150-1156.
23. Jones-Brando, L., Torrey, E.F. & Yolken, R. (2003). Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophrenia Research 62: 237-244.
24. Kaushik, R.M., Mahajan, S.K., Sharma, A., Kaushik, R. & Kukreti, R.M. (2005). Toxoplasmic meningoencephalitis in an immunocompetent host. Transactions of the Royal Society of Tropical Medicine and Hygiene 99: 874-878
25. Ledgerwood, L.G., Ewald, P.W. & Cochran, G.M. (2003). Genes, germs, and schizophrenia: an evolutionary perspective. Perspectives in Biology and Medicine 46: 317-348.
26. Leweke, F.M., Gerth, C.W., Koethe, D., Klosterkotter, J., Ruslanova, I., Krivogorsky, B., Torrey, E.F & Yolken, R.H. (2004). Antibodies to infectious agents in individuals with recent onset schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 254: 4-8.
27. Luder, C.G., Giraldo-Velasquez, M., Sendtner, M. & Gross, U. (1999). Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Experimental Parasitology 93: 23-32.
28. Montoya, J.G. & Liesenfeld, O. (2004). Toxoplasmosis. Lancet 363: 1965-1976.
29. Oberdorfer, C., Adams, O., Mackenzie, C.R., De Groot, C.J. & Daubener, W. (2003). Role of IDO activation in anti-microbial defence in human native astrocytes. Advances in Experimental Medicine and Biology 527: 15-26.
30. Qiuying, L., Xiaonian, L. & Li, L. (1999). The control study of schizophrenia and affective disorders and Toxoplasma infections. Acta Academiae Medicinae Hubei 20: 223-225.
31. Remington, J.S., McLeod, R., Thulliez, P. & Desmonts, G. (2001). Toxoplasmosis. In:. Infectious diseases in the Fetus and Newborn Infant. (Editors, R.S. Remington, J.O. Klein) pp224-227. W.B. Saunders, Philadelphia.
32. Saraei-Sahnesaraei, M., Shamloo, F., Jahani Hashemi, H., Khabbaz, F. & Alizadeh, S. A. (2009). Relation between Toxoplasma gondii infections and schizophrenia. Iranian Journal of Psychiatry and Clinical Psychology 15(1): 3-9.
33. Silva, L.A., Vieira, R.S., Seraini, L.N., Carlotti, C.G. Jr. & Figueiredo, J.F. (2001). Toxoplasmosis of the central nervous system in a patient without immunosupression: case report. Revista da Sociedade Brasileira de Medicina Tropical 34: 487-490.
34. Stanford, C.F., Connolly, J.H., Ellis, W.A., Smyth, E.T., Coyle, P.Y., Montgomery, W.I. & Simpson, D.I. (1990). Zoonotic infections in northern Ireland farmers. Epidemiology and Infection 105: 565-570.
35. Suzuki, Y. (2002). Host resistance in the brain against Toxoplasma gondii. Journal of Infectious Diseases 185(suppl 1): S 58-S 65.
36. Tenter, A.M., Heckeroth, A.R. & Weiss, L.M. (2000). Toxoplasma gondii from animals to humans. International Journal of Parasitology 30: 1217-1258.
37. Torrey, E.F., Bartko, J.J., Lun, Z.R., & Yolken, R.H. (2006). Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin 33(3): 729-736.
38. Torrey, E.F. & Yolken, R.H. (2003). Toxoplasma gondii and schizophrenia. Emerging Infectious Diseases 9(11): 1375-1380.
39. Webster, J.P., Lamberton, P.H.L., Donnelly, C.A. & Torrey, E.F. (2006). Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood- stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proceedings of The Royal Society 273: 1023-1030.
40. Yolken, R.H., Bachmann, S., Rouslanova, I., Lillechej, E., Ford, G., Torrey, E.F. & Schroeder, J. (2001). Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infectious Diseases 32: 842-844.